Search

Search Results

Results 111 - 120 of 121 for Zolpidem

Treatment of Middle-of-the-Night Insomnia

Health - 18 Jun 2019

Intermittent or middle-of-the-night Insomnia afflicts 10-40% of adults in the US population. It is characterized by nocturnal awakenings with difficulty in returning to sleep afterwards.
Fibromyalgia Pain Relief: Medications & Alternative Treatments

Health - 10 Jun 2019

Fibromyalgia is a medical condition characterized by widespread pain and fatigue. Although no cure is available, treatment can help reduce the severity of symptoms and improve the health-related...
List of Sedatives

Health - 23 Aug 2018

Sedatives encompass a wide variety of drugs with different mechanisms of action that can induce depression of the central nervous system (CNS). In the first part of the 20th century, the...
Using INTEGRA VIAFLO 96 System for Analysis of Drugs of Abuse

White Paper - 19 Jun 2017

Prior to LC-MS/MS analysis, sample preparation has to be done to eliminate matrix interferents from urine samples.
Paxlovid

Drug - 16 Apr 2026

Consumer Medicine Information (CMI) about Paxlovid intended for persons living in Australia.
Prezista

Drug - 27 Feb 2026

Consumer Medicine Information (CMI) about Prezista intended for persons living in Australia.
Prezcobix

Drug - 27 Feb 2026

Consumer Medicine Information (CMI) about Prezcobix intended for persons living in Australia.
Symtuza

Drug - 19 Jan 2026

Consumer Medicine Information (CMI) about Symtuza intended for persons living in Australia.
C-Flox

Drug - 25 Aug 2025

Consumer Medicine Information (CMI) about C-Flox intended for persons living in Australia.
Xtandi

Drug - 24 Feb 2025

Consumer Medicine Information (CMI) about Xtandi intended for persons living in Australia.

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.